866 related articles for article (PubMed ID: 21254063)
1. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
Berezhkovskiy LM
J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
[TBL] [Abstract][Full Text] [Related]
2. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
Berezhkovskiy LM
Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
[TBL] [Abstract][Full Text] [Related]
3. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
Berezhkovskiy LM
J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
[TBL] [Abstract][Full Text] [Related]
4. The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations.
Berezhkovskiy LM
J Pharm Sci; 2011 Nov; 100(11):5031-47. PubMed ID: 21766310
[TBL] [Abstract][Full Text] [Related]
5. Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body.
Berezhkovskiy LM
J Pharm Sci; 2013 Feb; 102(2):761-71. PubMed ID: 23233148
[TBL] [Abstract][Full Text] [Related]
6. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
Berezhkovskiy LM
J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
[TBL] [Abstract][Full Text] [Related]
7. Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters.
Berezhkovskiy LM
J Pharm Sci; 2009 Feb; 98(2):748-62. PubMed ID: 18506769
[TBL] [Abstract][Full Text] [Related]
8. On the determination of the time delay in reaching the steady state drug concentration in the organ compared to plasma.
Berezhkovskiy LM
J Pharm Sci; 2007 Dec; 96(12):3432-43. PubMed ID: 17628491
[TBL] [Abstract][Full Text] [Related]
9. Prediction of human oral plasma concentration-time profiles using preclinical data: comparative evaluation of prediction approaches in early pharmaceutical discovery.
Van den Bergh A; Sinha V; Gilissen R; Straetemans R; Wuyts K; Morrison D; Bijnens L; Mackie C
Clin Pharmacokinet; 2011 Aug; 50(8):505-17. PubMed ID: 21740074
[TBL] [Abstract][Full Text] [Related]
10. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
Ye M; Nagar S; Korzekwa K
Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
[TBL] [Abstract][Full Text] [Related]
11. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics.
Berezhkovskiy LM
J Pharm Sci; 2004 Feb; 93(2):364-74. PubMed ID: 14705193
[TBL] [Abstract][Full Text] [Related]
12. A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.
Berezhkovskiy LM
J Pharm Sci; 2010 Jan; 99(1):475-85. PubMed ID: 19492340
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods.
Poulin P; Theil FP
J Pharm Sci; 2009 Dec; 98(12):4941-61. PubMed ID: 19455625
[TBL] [Abstract][Full Text] [Related]
14. Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profiles.
Sobol E; Bialer M
Biopharm Drug Dispos; 2005 Mar; 26(2):51-8. PubMed ID: 15614832
[TBL] [Abstract][Full Text] [Related]
15. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
[TBL] [Abstract][Full Text] [Related]
16. Use of unbound volumes of drug distribution in pharmacokinetic calculations.
Stepensky D
Eur J Pharm Sci; 2011 Jan; 42(1-2):91-8. PubMed ID: 21050885
[TBL] [Abstract][Full Text] [Related]
17. Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.
Poulin P; Theil FP
J Pharm Sci; 2002 Jan; 91(1):129-56. PubMed ID: 11782904
[TBL] [Abstract][Full Text] [Related]
18. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
Mahmood I
Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
[TBL] [Abstract][Full Text] [Related]
19. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
Poulin P
J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
[TBL] [Abstract][Full Text] [Related]
20. Prediction of drug concentration-time data in humans from animals: a comparison of three methods.
Mahmood I; Goteti K
Xenobiotica; 2012 Aug; 42(8):756-65. PubMed ID: 22360447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
